Skip to main content
. 2017 May 2;8:738. doi: 10.3389/fmicb.2017.00738

Table 2.

Neonatal and maternal characteristics (n = 15).

Total cohort (n = 15) VD (n = 8) CSD (n = 7)a
INFANT CHARACTERISTICS
Female gender 7 (46.7%) 5 (62.5%) 2 (28.6%)
Gestational age at delivery (weeks) 38.7 ± 1.8 39 ± 1.5 38.3 ± 2.1
Birth weight (g) 3273 ± 416 3311 ± 543 3230 ± 236
MATERNAL CHARACTERISTICS
Positive group B Streptococcus screening 3 (21.4%) 3 (37.5%) 0
Age 33.6 ± 4.6 32.5 ± 4.4 35 ± 4.8
Postnatal body mass index 24 ± 4.3 21.8 ± 2.7 26.8 ± 4.6
ETHNICITY
    Caucasian 12 (85.7%) 7 (87.5%) 5 (83.3%)
    African 2 (14.3%) 1 (12.5%) 1 (16.7%)
Perinatal antibiotic intakeb 11 (78.6%) 6 (75%) 5 (83.3%)
    Penicillinc 6 (42.9%) 6 (75%) 0
    Cephalosporin 4 (28.6%) 0 4 (66.7%)
Clindamycin 1 (7.1%) 0 1 (16.7%)
Probiotic use during pregnancy 2 (14.3%) 1 (12.5%) 1 (16.7%)
a

2 C-section infants are twins.

b

Considering all antibiotics administered to the mother 12 h prior and after the delivery.

c

As ampicillin belongs to the penicillin group, ampicillin and penicillin intake were both categorized as “penicillin.”

Study groups are defined according to delivery mode (VD: n = 8; CSD: n = 7). CSD, C-section delivery; VD, vaginal delivery.